Axogen (AXGN) EBITDA Margin (2016 - 2025)
Axogen (AXGN) has 16 years of EBITDA Margin data on record, last reported at 16.31% in Q4 2025.
- For Q4 2025, EBITDA Margin fell 2040.0% year-over-year to 16.31%; the TTM value through Dec 2025 reached 3.49%, down 173.0%, while the annual FY2025 figure was 3.49%, 173.0% down from the prior year.
- EBITDA Margin reached 16.31% in Q4 2025 per AXGN's latest filing, down from 3.18% in the prior quarter.
- Across five years, EBITDA Margin topped out at 4.08% in Q4 2024 and bottomed at 36.51% in Q1 2022.
- Average EBITDA Margin over 5 years is 12.26%, with a median of 14.32% recorded in 2022.
- Peak YoY movement for EBITDA Margin: surged 1720bps in 2024, then tumbled -2040bps in 2025.
- A 5-year view of EBITDA Margin shows it stood at 16.97% in 2021, then rose by 9bps to 15.51% in 2022, then surged by 52bps to 7.44% in 2023, then skyrocketed by 155bps to 4.08% in 2024, then tumbled by -500bps to 16.31% in 2025.
- Per Business Quant database, its latest 3 readings for EBITDA Margin were 16.31% in Q4 2025, 3.18% in Q3 2025, and 2.95% in Q2 2025.